Literature DB >> 20827551

The flare phenomenon: still learning after 35 years.

Ignac Fogelman.   

Abstract

Mesh：

Year:  2011        PMID： 20827551     DOI： 10.1007/s00259-010-1609-8

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  4 in total

1.  The diagnostic utility of the flare phenomenon on bone scintigraphy in staging prostate cancer.

Authors:  Gary J R Cook; Ram Venkitaraman; Aslam S Sohaib; Valerie J Lewington; Sue C Chua; Robert A Huddart; Christopher C Parker; David D Dearnaley; Alan Horwich
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-08-10       Impact factor: 9.236

2.  Bone scan flare predicts successful systemic therapy for bone metastases.

Authors:  R E Coleman; G Mashiter; K B Whitaker; D W Moss; R D Rubens; I Fogelman
Journal:  J Nucl Med       Date:  1988-08       Impact factor: 10.057

3.  The assessment of response to therapy of bone metastases in breast cancer.

Authors:  M A Rossleigh; F T Lovegrove; P M Reynolds; M J Byrne; B P Whitney
Journal:  Aust N Z J Med       Date:  1984-02

4.  Detection of bone metastases in patients with lung cancer: 99mTc-MDP planar bone scintigraphy, 18F-fluoride PET or 18F-FDG PET/CT.

Authors:  Stefan Krüger; Andreas K Buck; Felix M Mottaghy; Ellen Hasenkamp; Sandra Pauls; Christian Schumann; Thomas Wibmer; Tobias Merk; Vinzenz Hombach; Sven N Reske
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-06-06       Impact factor: 9.236
  4 in total
  1 in total

1.  TLG-S criteria are superior to both EORTC and PERCIST for predicting outcomes in patients with metastatic lung adenocarcinoma treated with erlotinib.

Authors:  Kung-Chu Ho; Yu-Hua Dean Fang; Hsiao-Wen Chung; Yuan-Chang Liu; John Wen-Cheng Chang; Ming-Mo Hou; Cheng-Ta Yang; Nai-Ming Cheng; Tzu-Pei Su; Tzu-Chen Yen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-06-03       Impact factor: 9.236
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.